+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cryogenic Vials Market Research Report by Material, by Sterility, by End User, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5134284
  • Report
  • September 2021
  • Region: United States
  • 73 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Cryogenic Vials Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Cryogenic Vials Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cryogenic Vials to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Material, the Cryogenic Vials Market was studied across Polyethylene and Polypropylene.
  • Based on Capacity, the Cryogenic Vials Market was studied across Capacity 1 ml and Below, Capacity 1ml to 3 ml, Capacity 3 ml to 5 ml, and Capacity 5 ml and Above.
  • Based on Sterility, the Cryogenic Vials Market was studied across Gamma Irradiated, Non-Sterile, and Sterile.
  • Based on End User, the Cryogenic Vials Market was studied across Drug Manufacturer, Hospital & Diagnostic Center, and Research Organization.
  • Based on State, the Cryogenic Vials Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cryogenic Vials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Cryogenic Vials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Cryogenic Vials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Cryogenic Vials Market?
4. What is the competitive strategic window for opportunities in the United States Cryogenic Vials Market?
5. What are the technology trends and regulatory frameworks in the United States Cryogenic Vials Market?
6. What is the market share of the leading vendors in the United States Cryogenic Vials Market?
7. What modes and strategic moves are considered suitable for entering the United States Cryogenic Vials Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Material Outlook
3.4. Capacity Outlook
3.5. Sterility Outlook
3.6. End User Outlook
3.7. State Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Cryogenic Vials Market, by Material
6.1. Introduction
6.2. Polyethylene
6.3. Polypropylene

7. Cryogenic Vials Market, by Capacity
7.1. Introduction
7.2. Capacity 1 ml and Below
7.3. Capacity 1ml to 3 ml
7.4. Capacity 3 ml to 5 ml
7.5. Capacity 5 ml and Above

8. Cryogenic Vials Market, by Sterility
8.1. Introduction
8.2. Gamma Irradiated
8.3. Non-Sterile
8.4. Sterile

9. Cryogenic Vials Market, by End User
9.1. Introduction
9.2. Drug Manufacturer
9.3. Hospital & Diagnostic Center
9.4. Research Organization

10. California Cryogenic Vials Market
10.1. Introduction

11. Florida Cryogenic Vials Market
11.1. Introduction

12. Illinois Cryogenic Vials Market
12.1. Introduction

13. New York Cryogenic Vials Market
13.1. Introduction

14. Ohio Cryogenic Vials Market
14.1. Introduction

15. Pennsylvania Cryogenic Vials Market
15.1. Introduction

16. Texas Cryogenic Vials Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES CRYOGENIC VIALS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2020 (USD MILLION)
FIGURE 3. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2020 (USD MILLION)
FIGURE 4. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2020 (USD MILLION)
FIGURE 5. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 7. UNITED STATES CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CRYOGENIC VIALS MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2026 (%)
FIGURE 10. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2026
FIGURE 12. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2026 (%)
FIGURE 17. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2026
FIGURE 19. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1 ML AND BELOW, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1 ML AND BELOW, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1ML TO 3 ML, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1ML TO 3 ML, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 3 ML TO 5 ML, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 3 ML TO 5 ML, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 5 ML AND ABOVE, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 5 ML AND ABOVE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2020 VS 2026 (%)
FIGURE 28. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2020 VS 2026 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2026
FIGURE 30. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY GAMMA IRRADIATED, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY GAMMA IRRADIATED, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 32. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY NON-STERILE, 2018-2026 (USD MILLION)
FIGURE 33. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY NON-STERILE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 34. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILE, 2018-2026 (USD MILLION)
FIGURE 35. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 36. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 37. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END USER, 2026
FIGURE 39. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY DRUG MANUFACTURER, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY DRUG MANUFACTURER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTER, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY RESEARCH ORGANIZATION, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY RESEARCH ORGANIZATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 45. CALIFORNIA CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. FLORIDA CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. ILLINOIS CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. NEW YORK CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. OHIO CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. PENNSYLVANIA CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. TEXAS CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. UNITED STATES CRYOGENIC VIALS MARKET: FPNV POSITIONING MATRIX
FIGURE 53. UNITED STATES CRYOGENIC VIALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 54. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CRYOGENIC VIALS MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES CRYOGENIC VIALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1 ML AND BELOW, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1ML TO 3 ML, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 3 ML TO 5 ML, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 5 ML AND ABOVE, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY GAMMA IRRADIATED, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY NON-STERILE, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY DRUG MANUFACTURER, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTER, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY RESEARCH ORGANIZATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. CALIFORNIA CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. FLORIDA CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. ILLINOIS CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. NEW YORK CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. OHIO CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. PENNSYLVANIA CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. TEXAS CRYOGENIC VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES CRYOGENIC VIALS MARKET: SCORES
TABLE 28. UNITED STATES CRYOGENIC VIALS MARKET: BUSINESS STRATEGY
TABLE 29. UNITED STATES CRYOGENIC VIALS MARKET: PRODUCT SATISFACTION
TABLE 30. UNITED STATES CRYOGENIC VIALS MARKET: RANKING
TABLE 31. UNITED STATES CRYOGENIC VIALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 32. UNITED STATES CRYOGENIC VIALS MARKET: MERGER & ACQUISITION
TABLE 33. UNITED STATES CRYOGENIC VIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 34. UNITED STATES CRYOGENIC VIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 35. UNITED STATES CRYOGENIC VIALS MARKET: INVESTMENT & FUNDING
TABLE 36. UNITED STATES CRYOGENIC VIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 37. UNITED STATES CRYOGENIC VIALS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll